Fig. 1From: Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agentsFlow-chart for the analyses carried out in the participants during the study. DPP-4 dipeptidyl peptidase-4Back to article page